Will Agilon Health stock go up?

According to Danelfin AI, Agilon Health has today an AI Score of 2/10 (Strong Sell rating), because its probability of beating the market in 3 months (41.81%) is -9.00% vs. the average probability (50.82%) of all US-listed stocks.

What is the target price for Agilon Health stock?

The Agilon Health target price is $56.58 (1Y), according to the average price target offered by analysts.

Is it a good time to buy, sell, or hold Agilon Health stock right now?

Agilon Health has today a Strong Sell rating (AI Score 2/10), according to Danelfin AI. Its probability of beating the market in 3 months (41.81%) is -9.00% vs. the average probability (50.82%) of all US-listed stocks, based on our AI-powered analysis. You can find more details on whether Agilon Health stock is a good buy .

Is Agilon Health undervalued right now?

Based on analysts, the average price target downside for Agilon Health is -49.38% (1Y). According to Danelfin AI, Agilon Health has today an AI Score of 2/10 (Strong Sell Rating).

What was the price range of Agilon Health stock over the past 12 months?

The Agilon Health stock price range over the past 12 months has been $7.91 - $119.25.

What is going on with Agilon Health stock in the last 3 months?

The Agilon Health stock performance in the last quarter has been +1,313.02%.

Does Agilon Health offer dividend payments?

No, Agilon Health does not currently pay dividends.

What is the current market capitalization of Agilon Health?

Agilon Health's market cap is $1.86B, as of 2026-07-02 08:00.

When is the next AGL earnings report date?

AGL will publish its next earnings report on 2026-05-06.

agilon health inc (AGL) AI Stock Analysis

Advanced Chart

Custom range

Jul 3, 2025

→

Jul 3, 2026

Custom range

Jul 3, 2025

→

Jul 3, 2026

AGL AI-Powered Stock Analysis

AI Score Explanation

AI Score

Strong Sell

Fundamental
Technical
Sentiment
Low Risk

According to Danelfin’s proprietary AI model, agilon health inc today receives an AI Score of 2/10, which translates to a Sell rating. The stock has a 42% probability of outperforming the market in the next 3 months, which is 9% lower than the average probability of any stock (51%). The probability is weighed down by several negative factors. The most significant detractor is the long-term Chart Pattern (504d), which reduces the probability by -3.06%. The stock's classification in the Health Care Providers & Services industry also detracts by -1.25%, and negative sentiment from the long tail of sentiment signals contributes a -1.13% reduction. The only notable positive influence comes from the aggregated long tail of fundamental signals, which adds +1.34% to the probability. Notable data points that help explain this low probability include the stock's high volatility, with its Beta in the top 10% and its ATR (14d Volatility) also in the top 10%, indicating significantly higher risk than the market. Analyst sentiment is notably weak, with the Analyst Mean Price Target Upside in the bottom 10%. While the company's most recent quarterly Operating Cash Flow is a positive contributor, its trailing twelve-month Income is negative, reflecting underlying profitability challenges. The overall picture is one of a stock facing significant headwinds from technical patterns, sector positioning, high volatility, and weak analyst outlook, justifying its low AI Score and sell rating.

AI Score Explanation

Generating AI Score explanation

We're getting the explanation ready so you can easily understand what's behind the AI Score. This may take a few seconds.

Valuation+1.51%
How the stock is priced relative to its fundamentals
Earnings Quality+0.54%
Stability and reliability of reported earnings
Size & Liquidity+0.28%
Company size and trading liquidity

Momentum-5.33%
Direction and strength of recent price movements
Sentiment-3.62%
How analysts and the market view the stock
Volatility-2.38%
How much the stock price tends to fluctuate

AGL probability advantage of beating the market (3M):

-9.00%

Technical

Agilon Health (AGL) has a Technical Score of 1/10 because, according to only technical analysis, it has a probability advantage of -12.34% of beating the market (S&P500) in the next 3 months. This advantage is calculated as the difference between the average probability of any US-listed stock (50.64%) and the probability of AGL (38.30%) of overperforming the market in the next 3 months, as determined by Danelfin AI’s technical analysis.

Average probability of any US-listed stock of beating the market (3M)50.64%
AGL probability advantage of beating the market (only technical, 3M)-12.34%
AGL probability of beating the market (3M)38.30%

AGL probability advantage of beating the market (only technical, 3M): -12.34%

The AI-powered technical analysis of Agilon Health (AGL) is only based on the 30 technical features that had the greatest impact on stock performance during the last 12 months (alpha signals). These alpha signals explain the probability advantage of AGL:

Type	Alpha Signal	Probability Advantage Impact (3M)
Technical	Upgrade to Pro to unlock	-3.12%
Technical	Upgrade to Pro to unlock	-1.59%
Technical	Upgrade to Pro to unlock	+1.55%
Technical	Upgrade to Pro to unlock	-1.53%
Technical	Upgrade to Pro to unlock	+1.21%
Technical	Upgrade to Pro to unlock	-1.06%
Technical	Upgrade to Pro to unlock	-1.04%
Technical	Upgrade to Pro to unlock	-1.04%
Technical	Upgrade to Pro to unlock	-1.00%
Technical	Upgrade to Pro to unlock	-0.90%
Technical	Upgrade to Pro to unlock	-0.82%
Technical	Upgrade to Pro to unlock	-0.76%
Technical	Upgrade to Pro to unlock	+0.72%
Technical	Upgrade to Pro to unlock	-0.70%
Technical	Upgrade to Pro to unlock	-0.70%

Rest of Alpha Signals: -1.56%

AGL probability advantage of beating the market (only technical, 3M)Total:-12.34%
AGL Technical Score

Significant changes Vs previous day

AGL Short Trading Parameters

These suggested trading parameters for a 3-month horizon help improve risk management and decision-making.

Entry:$111.77
Horizon: 3 months
Stop Loss:$XXXXXPro (XXXXXPro)
Take Profit:$XXXXXPro (XXXXX
Pro
)

AGL Proven Sell Signal & Price Forecast

This is the price chart for AGL from January 1, 2026 until today. The chart indicates, in red, the 59 days when the stock received a Sell/Strong Sell rating (sell signals, AI Score 1 to 3).

Forecast: In the section below, the central dotted line represents the most expected path, while the shaded area indicates the anticipated price range. This is based on previous Sell signals with a 90% confidence level.

Full Track Record

Unlock AI-powered forecast

Closing price (USD)
Sell signals

Forecast:

1 Month
3 Months
6 Months
1 Year

AGL Average Past Performance & Loss Rate

Three months after its 501 Sell signals since July 2026, AGL had an average performance of xxxxxx and a xxxxxx Loss rate (negative performance).

501 Past AGL Sell Signals	1 Month Later	3 Months Later	6 Months Later	1 Year Later
Average Performance				-27.53%
Average Alpha				-33.79%
Loss Rate (% Negative Perf.)				76.79%
% Negative Alpha				73.21%

AGL Frequently Asked Questions

Will Agilon Health stock go up?
According to Danelfin AI, Agilon Health has today an AI Score of 2/10 (Strong Sell rating), because its probability of beating the market in 3 months (41.81%) is -9.00% vs. the average probability (50.82%) of all US-listed stocks.
What is the target price for Agilon Health stock?
Is it a good time to buy, sell, or hold Agilon Health stock right now?
Is Agilon Health undervalued right now?
What was the price range of Agilon Health stock over the past 12 months?
What is going on with Agilon Health stock in the last 3 months?
Does Agilon Health offer dividend payments?
What is the current market capitalization of Agilon Health?
When is the next AGL earnings report date?

agilon health inc Company Profile

Agilon Health, Inc., a healthcare services company, primarily focuses on senior patients within the United States' communities. They deliver their services primarily via primary care doctors. The company utilizes a platform structured to manage a patient's all-encompassing health needs on a per-member per-month subscription basis, granting both convenience and comprehensive care in a package Devised initially under the name Agilon Health Topco, Inc., it revised its name to agilon health, inc. in March of 2021 reflecting its evolving identity while maintaining consistency in its commitment to quality health care provision. The inception of the firm dates back to 2016 and is headquartered at Austin, Texas, continuing its operations from this location ever since.

Sector:Health Care
Country:United States
Industry:Health Care Providers & Services
Address:440 Polaris Parkway, Suite 550, Westerville
Employees:856
Website:agilonhealth.com

Pros

Long-term tailwinds from value-based care adoption

High switching costs for integrated physician practices

Local market network effects from patient and provider density

Predictable revenue from capitated payment arrangements

Scalable platform for physician practice integration

Cons

Exposure to Medicare Advantage regulatory changes

Financial performance tied to partner physician outcomes

Capital intensity for new market expansion

Competition in value-based care market

Reliance on patient enrollment and retention

Company	AI Score	Compare
ELVElevance Health Inc

Company	AI Score	Compare
ELVElevance Health Inc

AGL Stock AI Analysis High Risk